Abstract
Importance: Postmortem genetic testing of young individuals with sudden death has previously identified pathogenic gene variants. However, prior studies primarily considered highly penetrant monogenic variants, often without detailed decedent and family clinical information. Objective: To assess genotype and phenotype risk in a diverse cohort of young decedents with sudden death and their families. Design, Setting, and Participants: Pathological and whole-genome sequence analysis was conducted in a cohort referred from a national network of medical examiners. Cases were accrued prospectively from May 2015 to March 2019 across 24 US states. Analysis began September 2016 and ended November 2020. Exposures: Evaluation of autopsy and clinical data integrated with whole-genome sequence data and family member evaluation. Results: A total of 103 decedents (mean [SD] age at death, 23.7 [11.9] years; age range, 1-44 years), their surviving family members, and 140 sex- and genetic ancestry-matched controls were analyzed. Among 103 decedents, autopsy and clinical data review categorized 36 decedents with postmortem diagnoses, 23 decedents with findings of uncertain significance, and 44 with sudden unexplained death. Pathogenic/likely pathogenic (P/LP) genetic variants in arrhythmia or cardiomyopathy genes were identified in 13 decedents (12.6%). A multivariable analysis including decedent phenotype, ancestry, and sex demonstrated that younger decedents had a higher burden of P/LP variants and select variants of uncertain significance (effect size, -1.64; P =.001). These select, curated variants of uncertain significance in cardiac genes were more common in decedents than controls (83 of 103 decedents [86%] vs 100 of 140 controls [71%]; P =.005), and decedents harbored more rare cardiac variants than controls (2.3 variants per individual vs 1.8 in controls; P =.006). Genetic testing of 31 parent-decedent trios and 14 parent-decedent dyads revealed 8 transmitted P/LP variants and 1 de novo P/LP variant. Incomplete penetrance was present in 6 of 8 parents who transmitted a P/LP variant. Conclusions and Relevance: Whole-genome sequencing effectively identified P/LP variants in cases of sudden death in young individuals, implicating both arrhythmia and cardiomyopathy genes. Genomic analyses and familial phenotype association suggest potentially additive, oligogenic risk mechanisms for sudden death in this cohort..
Original language | English (US) |
---|---|
Pages (from-to) | 1247-1256 |
Number of pages | 10 |
Journal | JAMA cardiology |
Volume | 6 |
Issue number | 11 |
DOIs | |
State | Published - Nov 2021 |
Funding
reported grants from the National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute and the American Heart Association during the conduct of the study. Dr Puckelwartz reported grants from the NIH/National Heart, Lung, and Blood Institute and the American Heart Association during the conduct of this study. Dr Kofman reported grants from the NIH during the conduct of the study. Dr George reported grants from NIH/ National Heart, Lung, and Blood Institute, Praxis Precision Medicines, and Tevard Biosciences and personal fees from consulting for Amgen outside the submitted work. Dr McNally reported grants from the NIH and American Heart Association to Northwestern University during the conduct of the study; personal fees from Amgen, Avidity, AstraZeneca, 4D Molecular Therapeutics, Cytokinetics, Janssen Pharmaceuticals, Pfizer, PepGen, Tenaya, and Invitae outside the submitted work; and is founder of Ikaika Therapeutics. No other disclosures were reported. publication was supported, in part, by the National Institutes of Health/National Heart, Lung and Blood Institute (grants KL2TR001424, K23HL130554, R01HL128075, and U01HL131914), the American Heart Association Mentored Clinical and Population Research Award (17MCPRP33660457), the American Heart Association Career Development Award (189CDA34110460), the American Heart Association Strategically Focused Research Network on Sudden Cardiac Death and Arrhythmias
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine